| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $748.5M | +24.5% |
| Cost of Revenue | $468.5M | +28.4% |
| Gross Profit | $280.0M | +18.5% |
| R&D Expense | $118.6M | +13.9% |
| SG&A Expense | $71.7M | +9.7% |
| Operating Income | -$20.1M | +43.4% |
| Interest Expense | $3.0M | -19.8% |
| Income Tax | -$2.4M | +17.9% |
| Net Income | -$6.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.8M | -38.0% |
| Short-term Investments | $2.0M | -90.8% |
| Accounts Receivable | $86.5M | +10.6% |
| Current Assets | $187.8M | -25.7% |
| Total Assets | $989.2M | -10.2% |
| Current Liabilities | $140.3M | +14.3% |
| Long-term Debt | $281.3M | -32.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $83.9M | +115.1% |
| Investing Cash Flow | -$1.4M | -104.7% |
| Financing Cash Flow | -$131.3M | -148.7% |
| +60.1% |
| EPS (Basic) | -$0.24 | +62.5% |
| EPS (Diluted) | -$0.24 | +62.5% |
| Total Liabilities |
| $676.6M |
| -15.8% |
| Stockholders' Equity | $312.5M | +5.1% |